Navigation Links
Dr. Malgorzata Borowiak returns to the MDC from Harvard
Date:9/29/2011

This press release is available in German.

Dr. Malgorzata Borowiak, a researcher in the Department of Stem Cell and Regenerative Biology at Harvard University in Cambridge, MA, USA, has been awarded a grant from the Helmholtz Association to return to the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, as head of a Young Investigators Group. At the MDC, which is a member of the Helmholtz Association, Dr. Borowiak aims to contribute to diabetes research by studying the molecular basis of beta cell development. These cells, which produce insulin, a hormone essential for life, are defective in diabetics. Dr. Borowiak will also cooperate with Charit - Universittsmedizin Berlin.

Dr. Borowiak holds a Master's degree in Biotechnology from Adam Mickiewicz University in Poznań, Poland and completed her doctoral work under the supervision of Professor Carmen Birchmeier (MDC/Freie Universitt Berlin). She received her PhD degree in 2006 and then went to the U.S. for her postdoctoral work.

Altogether, this year the Helmholtz Association awarded Young Investigator grants to twenty early-stage researchers, ten of whom are women. They were selected from 226 applicants. With an annual budget of "at least 250, 000 euros over a period of five years and the prospect of gaining a tenure-track position", these grants, according to the Helmholtz Association, "are an ideal entry into a scientific career and are therefore attractive both for foreign applicants and for researchers who wish to return to Germany from a research stay abroad."

Half of the money will come from the Initiative and Networking Fund of the President of the Helmholtz Association and the other half from the research center at which the leader of the Young Investigators Group will work. Currently there are seven Helmholtz Young Investigators Groups at the MDC,
'/>"/>

Contact: Barbara Bachtler
bachtler@mdc-berlin.de
49-309-406-3896
Helmholtz Association of German Research Centres
Source:Eurekalert

Page: 1 2

Related biology news :

1. Science returns to the Capitol Hill spotlight at March 24 exhibition
2. Science returns to Capitol Hill spotlight at April 14 exhibition
3. The LouseBuster returns
4. VIMS team returns to Antarctic Peninsula
5. Oldest known wild bird in US returns to Midway to raise chick
6. Research ship Polarstern returns from Antartica
7. Organizational Change Management for Sustainability: The Harvard Case Study
8. Harvard scientist says we are what we eat -- and what we cook
9. Duke, Harvard researchers to monitor bonobo reintroduction
10. Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection
11. Harvard research team receives $10M NSF grant to develop small-scale mobile robotic devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announces ... CEO Conference on January 29 th at 10:30 ... CEO of NXT-ID will present and host a live ... wallet and its full suite of biometric technologies. Investors ...
(Date:1/22/2015)... , Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: ... market in general the State of Washington,s ... for a new enrollment and central issuance system for driver,s ... The project planning and development will start in ...
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... Singh Malik, Ph.D., of Fred Hutchinson Cancer Research Center, ... Institute to study the potential role of "genetic conflicts" ... Malik and colleagues want to find out whether a ... to determine whether autoimmunity when the body,s immune ...
... , ,A Griffith University PhD candidate has been highly awarded ... atom. Ben Norton, from the Kielpinski group in ... CiSRA Extreme Imaging Competition following extensive work on high resolution ... Inc.,s Australian research centre, the Extreme Imaging competition aims to ...
... is available in French . Vancouver, B.C. -- ... place at the wrong time. As a result of changing conditions, marine ... as three kilometres per year over the past 50 years, and forecasts ... years. Decisions on where to put MPAs weren,t always made with ...
Cached Biology News:Did an evolutionary arms race cause lupus? Biologist Harmit Malik receives grant to try and find out 2Extreme imaging wins science praise 2Marine protected areas: changing climate could require change of plans 2
(Date:2/27/2015)... BOSTON , Feb. 27, 2015   PureTech ... identifying, inventing and commercializing disruptive products and technologies in ... Christopher Viehbacher , former CEO and Member of the ... Directors.  "It,s has been a pleasure ... very excited that we will be working together more ...
(Date:2/26/2015)... WOODBRIDGE, N.J. , Feb. 26, 2015 ... and its affiliated companies, Wilentz, Goldman & ... a trade secrets lawsuit against Genewiz Inc. in excess ... obtained and utilized GenScript,s trade secrets, and that it ... court entered an order denying motions for judgment notwithstanding ...
(Date:2/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... fiscal first quarter ended December  31, 2014. All figures ... unless otherwise stated. "During the quarter ... existing customers and add to our sales pipeline," said ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015   Regulus ... biopharmaceutical company leading the discovery and development of innovative ... Xanthopoulos , Ph.D., President and Chief Executive Officer of ... and Company 35 th Annual Healthcare Conference on ... conference is being held at the Boston Marriott Copley ...
Breaking Biology Technology:Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
... LLC of Irvine, California today announced a strategic ... CompanDX have forged a unique partnership to offer ... molecular diagnostic tests for clients in the healthcare ... deliver small composite biomarker signatures from complex data ...
... BOTHELL, Wash., June 16, 2011 SCOLR Pharma, Inc. ... sale of $1 million principal amount of its 8% ... an initial closing of its private offering of up ... may offer additional Debentures, up to the aggregate maximum ...
... , -- " Ask,Extractor ... " Help Researchers Narrow Search Results,-- ... information products and services, today announced two new,applications from Molecular ... Ask Extractor is an application based on Molecular ...
Cached Biology Technology:ResearchDx and CompanDX Announce Strategic Partnership 2SCOLR Pharma, Inc. Announces Initial Closing of Private Placement 2SCOLR Pharma, Inc. Announces Initial Closing of Private Placement 3Elsevier and Molecular Connections Develop Two New Applications on SciVerse Applications 2Elsevier and Molecular Connections Develop Two New Applications on SciVerse Applications 3Elsevier and Molecular Connections Develop Two New Applications on SciVerse Applications 4Elsevier and Molecular Connections Develop Two New Applications on SciVerse Applications 5Elsevier and Molecular Connections Develop Two New Applications on SciVerse Applications 6
Recommend to use at up to 5000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...
Prepared in distilled water....
... Weight Markers, 37 kBq, 1 uCi. Carbon-14 ... of the sample on Western blots.The Rainbow-labeled ... migration in the gel and on the ... without Rainbow-labeling is 0.37-3.7 MBq/mg (10-100 uCi/mg) ...
in vitro Translation, Accessory Products...
Biology Products: